Initiative to Maximize Research Education in Genomics: Courses (R25)

The summary for the Initiative to Maximize Research Education in Genomics: Courses (R25) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Initiative to Maximize Research Education in Genomics: Courses (R25): This funding opportunity supports short, advanced level courses that are intended to disseminate new techniques, methods, and analyses related to the mission of the NHGRI.
Federal Grant Title: Initiative to Maximize Research Education in Genomics: Courses (R25)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: PAR-13-012
Type of Funding: Grant
CFDA Numbers: 93.172
CFDA Descriptions: Human Genome Research
Current Application Deadline: May 07, 2016
Original Application Deadline: May 07, 2016
Posted Date: Oct 26, 2012
Creation Date: Oct 26, 2012
Archive Date: Jun 07, 2016
Total Program Funding:
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: No
Applicants Eligible for this Grant
State governments - Public and State controlled institutions of higher education - Native American tribal governments (Federally recognized) - Native American tribal organizations (other than Federally recognized tribal governments) - Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education - Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education - Private institutions of higher education - For profit organizations other than small businesses - Small businesses - Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grant Announcement Contact
NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants
Genomic Innovator Award (R35 Clinical Trial Optional)
Center for ELSI Resources and Analysis (U24 Clinical Trial Not Allowed)
Novel Approaches for Relating Genetic Variation to Function and Disease (R01 Clinical Tria...
Novel Approaches for Relating Genetic Variation to Function and Disease (R21 Clinical Tria...
Investigator Initiated Research in Computational Genomics and Data Science (R21 Clinical T...
Near-Term Technology Development for Genome Sequencing - SBIR (R43/R44)
Near-Term Technology Development for Genome Sequencing - STTR (R41/R42)
Revolutionary Genome Sequencing Technologies - The $1000 Genome - SBIR (R43/R44)
More Grants from the National Institutes of Health
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R01 Clini...
Analytical and/or Clinical Validation of a Candidate Biomarker for Pain (R61/R33 Clinical ...
Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical T...
Discovery and Validation of Novel Targets for Safe and Effective Pain Treatment (R21 Clini...
Loyalty and Reward-Based Technologies to Increase Adherence to Substance Use Disorder Phar...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2018 FederalGrants.com